Zhang et al. in the 214 meta-analysis, by including 26 studies containing 12,776 cases and 6371 controls, indicated that MMP-9 (C1562T) polymorphism was not associated with the risk of CAD in the overall results [69]. Here, MMP9 is linked to coronary artery disorder.